Creative Details

Quality Score: 5/10

The advertisement promotes CABOMETYX as a treatment option for specific types of neuroendocrine tumors in patients aged 12 and older, highlighting its use for cases that cannot be treated by surgery.

Creative Information

CID:a6361ad3-0a47-44da-a331-23c0a2eaef49
CRID:82_6157-850397
Domain:exelixis.com
Seat:PP
Size:728x90
Bid:$0.17
Timestamp:11/1/2025, 4:22:01 AM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/1/2025, 4:39:35 AM6.21s
    adomain_analysissuccess11/1/2025, 5:26:35 AM3.46s
    adomain_capturesuccess11/1/2025, 5:25:56 AM0.17s
    ad_rendersuccess11/1/2025, 4:39:29 AM27.12s
    brand_mappingsuccess11/1/2025, 4:22:01 AM0.10s

    Analysis Results

    Ad Format: banner

    Brands: Exelixis

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:728x90
    Data Transferred:1643.89 KB
    Render Time:11.10 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Science (IAB15)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    Landing Page:
    https://ma2-tr.contextweb.com/bh/ct2?i=i4Rz7XH8xsh...
    Domain:ma2-tr.contextweb.com
    Brand:
    Internet Archive
    Total Ad Size:1643.97 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js523.93
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js221.47
    https://s0.2mdn.net/ads/studio/Enabler.js153.28
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N6246.620333PULSEPOINT/B33271959.417289989;dc_ver=106.314;dc_eid=40004001;sz=728x90;u_sd=1;gdpr_consent=AUDIT;nel=1;kw=2408842;dvs1=6157;dvs2=6157;dvs3=1;dvs4=562001;dvs5=228712;dvs6=677254;dvs7=228;dvs9=561937;dc_adk=3706686476;ord=9ewdwn;click=https%3A%2F%2Fma2-tr.contextweb.com%2Fbh%2Fct2%3Fi%3Di4Rz7XH8xshl~a%3D8da0721e145d0263b714574b0a0000e1c39917fb~agi%3D228712~ts%3Ds6YkQ5bIZS9Ok0rQrLB2gscW1Vn-OTcr~es%3D2~c%3D2408842~p%3D562001~pu%3Dhttps%253A%252F%252Fwww.upworthy.com%252Fhow-to-be-more-likable~s%3Dcontextweb.com~dt%3D5~u%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=pVm89'q!9R;gcsr=m;stc=1;chaa=1;sttr=200;prcl=s100.55
    https://s0.2mdn.net/sadbundle/8923987314359268445/img/f2-patient.png74.11
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://cdnjs.cloudflare.com/ajax/libs/gsap/3.9.0/gsap.min.js62.66
    https://ep1.adtrafficquality.google/bg/JZ8w1i8bx3cDZQSBxsx5w15uhXHOiRxKXBGDxXBp4-A.js52.91
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1